MIV Therapeutics

Related Articles

Clinical Trial/Study

New Polymer-Free DES Technology Highlighted in JACC Intervention

Stents

New Polymer-Free DES Technology Highlighted in JACC Intervention
MIV Provides Study Update on Its Ultra-Thin Protea Stent Platform
MIV Therapeutics Sells Subsidiary for $4 Million
MIV Gets Regulatory Approval For Two Bare Metal Stents in India

Stents, Drug Eluting

New Polymer-Free DES Technology Highlighted in JACC Intervention
VESTAsync DES Trials Report Positive Results
First Patients Enrolled in MIV Therapeutics VESTASYNC II Study
Human Study Demonstrates Safety Of Polymer-Free DES
Results on Low Dose Polymer-Free DES Presented at TCT
Testing Validates Polymer-Free Delivery System in MIV Therapeutic’s DES
Novel Polymer-free DES Showing Promise

Cardiology Products

New Polymer-Free DES Technology Highlighted in JACC Intervention

General Cardiology

New Polymer-Free DES Technology Highlighted in JACC Intervention
MIV Provides Study Update on Its Ultra-Thin Protea Stent Platform

Embolic Protection Devices

Stroke Prevention Device Obtains Favorable Results

Vena Cava Filters

Stroke Prevention Device Obtains Favorable Results